Augmenting autophagy for prognosis based intervention of COPD-pathophysiology

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Molecular Medicine

Background:

• Chronic obstructive pulmonary disease (COPD) is a major fatal lung disease linked to smoking and aging.
• Smoke exposure triggers inflammation, oxidative stress, apoptosis, and senescence, contributing to emphysema.
• The underlying regulatory mechanisms for these processes in COPD were previously unclear.

Discussion:

• Proteostasis and autophagy play central roles in COPD pathogenesis.
• Cigarette smoke impairs autophagy, causing polyubiquitinated protein accumulation (aggresomes), correlating with emphysema severity.
• Autophagy-inducing drugs, including FDA-approved antioxidants, mitigate smoke-induced damage in preclinical COPD models.

Key Insights:

• Aggresome pathology serves as an early indicator of COPD-emphysema severity.
• Targeting autophagy presents a therapeutic strategy for COPD.
• Autophagy modulation can reduce inflammation, oxidative stress, and apoptosis in COPD.

Outlook:

• Early detection of aggresomes can guide prognosis-based interventions for COPD patients.
• Autophagy-inducing therapies are expected to decrease alveolar damage and lung function decline.
• This approach holds potential for reducing mortality rates in COPD-emphysema.